COVID-19: Prioridad ONE

Este es un espacio multidisciplinar dirigido a profesionales de la salud que luchan cada día contra el COVID-19.

Su objetivo es incorporar de forma regular publicaciones científicas, guías o recomendaciones que puedan ayudar al profesional a conocer mejor la enfermedad, su diagnóstico y su manejo terapéutico.

A pesar de hacer un filtrado previo, queremos poner de manifiesto que en la selección de artículos que incluimos probablemente no todos cuenten con el mismo nivel de calidad. No hay, ni habrá por ejemplo, publicaciones basadas en medicinas alternativas, pero es posible encontrar algunas publicaciones que estén realizadas con grupos pequeños de pacientes, circunstancia justificada por la presión del tiempo para salvar pacientes de compartir con los profesionales los pequeños avances de cada día.

Dejamos a criterio del profesional de la medicina la valoración de estas publicaciones.

CLASIFICACIÓN POR ÁREAS TEMÁTICAS

GUÍAS Y RECOMENDACIONES

Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 Mar 28. doi: 10.1007/s00134-020-06022-5. [Epub ahead of print]

Documentos técnicos para profesionales del Ministerio de Sanidad, Consumo y Bienestar Social

POSICIONAMIENTO Y RECOMENDACIONES SEMICYUC

Plan de Contingencia para los Servicios de Medicina Intensiva frente a la pandemia COVID-19.

Recomendaciones del GTEIS-SEMICYUC para el manejo inicial de la vía aérea en pacientes con sospecha de coronavirus.

Recomendaciones éticas para la toma de decisiones en la situación excepcional de crisis por pandemia COVID-19 en las unidades de cuidados intensivos (SEMICYUC).

Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. WHO/COVID-19/laboratory/2020.5

Montero Feijoo A, et al. Recomendaciones prácticas para el manejo perioperatorio del paciente con sospecha o infección grave por coronavirus SARS-CoV-2. Rev Esp Anestesiol Reanim. 2020. https://doi.org/10.1016/j.redar.2020.03.003.

Thomas-Rüddel D, Winning J, Dickmann P et al. Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020. Anaesthesist. 2020 Mar 24. doi: 10.1007/s00101-020-00760-3. [Epub ahead of print]

Barazzoni R et al. ESPEN expert statements and practical guidance for nutritional management of individuals with. SARS-CoV-2 infection, Clinical Nutrition, https://doi.org/10.1016/j.clnu.2020.03.022

Recomendaciones SEUP por SARS-CoV-2 (cuadro clínico: COVID-19)

SARS-CoV-2

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Robert F. Garry RF. The proximal origin of SARS-CoV-2. Nat Med (2020). https://doi.org/10.1038/s41591-020-0820-9.

Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.

Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W et al. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins. Viruses. 2020 Mar 25;12(4). pii: E360. doi: 10.3390/v12040360.

Dawood AA. Mutated COVID-19, May Foretells Mankind in a Great Risk in the Future. New Microbes New Infect. 2020;35:100673. doi:10.1016/j.nmni.2020.100673 [published online ahead of print, 2020 Apr 4]

Sportelli MC, Izzi M, Kukushkina EA, et al. Can Nanotechnology and Materials Science Help the Fight against SARS-CoV-2?. Nanomaterials (Basel). 2020;10(4):E802. Published 2020 Apr 21. doi:10.3390/nano10040802

EPIDEMIOLOGÍA

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 Feb 26:102433.

Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A Systematic Review of COVID-19 Epidemiology Based on Current Evidence. J Clin Med. 2020 Mar 31;9(4). pii: E967. doi: 10.3390/jcm9040967.

CLÍNICA

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513.

Hajifathalian K, Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F et al. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. World J Gastroenterol 2020 April 14; 26(14): 1546-1553.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020. doi: 10.1111/all.14238. [Epub ahead of print].

Vetter Pauline, Vu Diem Lan, L’Huillier Arnaud G, Schibler Manuel, Kaiser Laurent, Jacquerioz Frederique et al. Clinical features of covid-19. BMJ 2020; 369 :m1470

Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L et al. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020 Mar 31. doi: 10.1001/jamaophthalmol.2020.1291. [Epub ahead of print]

DIAGNÓSTICO

Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Feb 21:200490.

Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W et al. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology. 2020 Feb 26:200642. doi: 10.1148/radiol.2020200642. [Epub ahead of print]

Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C et al. Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol. 2020 Mar 25;126:108961. doi: 10.1016/j.ejrad.2020.108961. [Epub ahead of print]

Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. 2020 Mar 19. doi: 10.1007/s00330-020-06801-0. [Epub ahead of print]

Zhang G, Nie S, Zhang Z, Zhang Z. Longitudinal Change of SARS-Cov2 Antibodies in Patients with COVID-19. J Infect Dis. 2020;jiaa229. doi:10.1093/infdis/jiaa229 [published online ahead of print, 2020 May 2]

TRATAMIENTO

Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar;55(3):105924.

Valk SJ, Piechotta V, Chai KL, Doree C, Monsef I, Wood EM, Lamikanra A, Kimber C, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a rapid review. Cochrane Database of Systematic Reviews 2020, Issue 5. Art. No.: CD013600. DOI: 10.1002/14651858.CD013600.

Mackey K, King VJ, Gurley S, et al. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. Ann Intern Med. 2020;10.7326/M20-1515. doi:10.7326/M20-1515 [published online ahead of print, 2020 May 15]

Ahsan W, Javed S, Bratty MA, Alhazmi HA, Najmi A. Treatment of SARS-CoV-2: How far have we reached? Drug Discov Ther. 2020;14(2):67‐72. doi:10.5582/ddt.2020.03008

INMUNIDAD

Wen W, Su W, Tang H, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31. Published 2020 May 4. doi:10.1038/s41421-020-0168-9

Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020;52(5):737‐741. doi:10.1016/j.immuni.2020.04.012

Vardhana SA, Wolchok JD. The many faces of the anti-COVID immune response. J Exp Med. 2020;217(6):e20200678. doi:10.1084/jem.20200678

Grifoni A, Weiskopf D, Ramirez SI et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell (2020), doi: https://doi.org/10.1016/j.cell.2020.05.015

MORBILIDAD

William Gardner, David States & Nicholas Bagley (2020). The Coronavirus and the Risks to the Elderly in Long-Term Care. Journal of Aging & Social Policy, DOI: 10.1080/08959420.2020.1750543

Andrew M. South, Laurie Tomlinson, Daniel Edmonston, Swapnil Hiremath  and Matthew A. Sparks. Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol (2020). https://doi.org/10.1038/s41581-020-0279-4

Zhou F, Yu T, Du R,Fan G, Liu Y, Liu Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11. pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3. [Epub ahead of print].

Singh AK, Gupta R, Ghosh A, Misra A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020;14(4):303‐310. doi:10.1016/j.dsx.2020.04.004 [published online ahead of print, 2020 Apr 9]

GESTACIÓN

Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect. 2020 Mar 20. pii: S0163-4453(20)30118-3. doi:10.1016/j.jinf.2020.03.007. [Epub ahead of print]

PACIENTES PEDIÁTRICOS

Xia W, Shao J, Guo Y, Peng X, Li Z, Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr Pulmonol. 202. doi: 10.1002/ppul.24718. [Epub ahead of print].

Zhang T, Cui X, Zhao X, Wang J, Zheng J, Zheng G et al. Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795. [Epub ahead of print].

Tagarro A, Epalza C, Santos M, Sanz-Santaeufemia FJ, Otheo E, Moraleda C et al. Screening and Severity of Coronavirus Disease 2019. (COVID-19) in Children in Madrid, Spain. JAMA Pediatr. 2020 Apr 8. doi: 10.1001/jamapediatrics.2020.1346. [Epub ahead of print]

Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.

PARÁMETROS DE LABORATORIO

Ye G, Pan Z, Pan Y, Deng Q, Chen L, Li J et al. Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation. J Infect. 2020 Mar 11. pii: S0163-4453(20)30114-6. doi: 10.1016/j.jinf.2020.03.001. [Epub ahead of print]

Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med. 2020 Mar 13. pii: S2213-2600(20)30119-3.

Chen X, Yang Y, Huang M, Liu L, Zhang X, Xu J et al. Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center. J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25810. [Epub ahead of print]

Galli C, Plebani M. Clinical laboratory and SARS-CoV-2 infection: where do we stand? Clin Chem Lab Med. 2020 Apr 2. pii: /j/cclm.ahead-of-print/cclm-2020-0372/cclm-2020-0372.xml. doi: 10.1515/cclm-2020-0372. [Epub ahead of print]

Lippi G, Plebani M. Laboratory abnormalities in patients with COVID-2019 infection. Clin Chem Lab Med. 2020 Mar 3. pii: /j/cclm.ahead-of-print/cclm-2020-0198/cclm-2020-0198.xml. doi: 10.1515/cclm-2020-0198. [Epub ahead of print]

Velavan TP, Meyer CG. Mild versus severe COVID-19: Laboratory markers. Int J Infect Dis. 2020;95:304‐307. doi:10.1016/j.ijid.2020.04.061 [published online ahead of print, 2020 Apr 25]

AFECTACIONES

CARDIACA

Shi S, Qin M, Shen B, Cai Y, Liu T,Yang F6 et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25. doi: 10.1001/jamacardio.2020.0950. [Epub ahead of print]

Bansal M. Cardiovascular Disease and COVID-19. Diabetes Metab Syndr. May-Jun 2020;14(3):247-250. doi: 10.1016/j.dsx.2020.03.013. Epub 2020 Mar 25.

HEPÁTICA

Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1. Epub 2020 Mar 4.

NEUROLÓGICA

Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 Apr 10. doi: 10.1001/jamaneurol.2020.1127. [Epub ahead of print]

RENAL

Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020 Mar 20. pii: S0085-2538(20)30255-6. doi: 10.1016/j.kint.2020.03.005. [Epub ahead of print]

IMPACTO PSICOLÓGICO

Jianbo Lai, Simeng Ma, YingWang et al. Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019. JAMA Network Open. 2020;3(3):e203976. doi:10.1001/jamanetworkopen.2020.3976

Cuiyan Wang, Riyu Pan, XiaoyangWan et al. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int. J. Environ. Res. Public Health 2020, 17, 1729; doi:10.3390/ijerph17051729.

Dewey C, Hingle S, Goelz E, Linzer M. Supporting Clinicians During the COVID-19 Pandemic. Ann Intern Med. 2020 Mar 20. doi: 10.7326/M20-1033. [Epub ahead of print]